Skip Nav Destination

Issues

Select Year

Issue

Search within issue:

Search within issue

Proceedings of the 1st World Congress on Controversies in Diabetes, Obesity and Hypertension (CODHy)

Introduction

The Controversies in Obesity, Diabetes and Hypertension (CODHy) Meeting : What is it all about?

Itamar Raz, MD; Ram Weiss, MD, PHD

Abstracts

View articletitled, The Controversies in Obesity, Diabetes and Hypertension (CODHy) Meeting : What is it all about?

Open the PDF for in another window

Topics: hypertension and diabetes , obesity

Diabetes Care February 2008, Vol.31, S111-S112. doi:https://doi.org/10.2337/dc08-s226

Section I: Diabetes-What Is New in the Management and Understanding of the Disease?

Prevention of Hypoglycemia While Achieving Good Glycemic Control in Type 1 Diabetes : The role of insulin analogs

Paolo Rossetti, MD; Francesca Porcellati, MD, PHD; Geremia B. Bolli, MD; Carmine G. Fanelli, MD, PHD

Abstracts

View articletitled, Prevention of Hypoglycemia While Achieving Good Glycemic Control in Type 1 Diabetes : The role of insulin analogs

Open the PDF for in another window

Topics: hypoglycemia , diabetes mellitus, type 1 , insulin , hypoglycemia unawareness , insulin analogs

Diabetes Care February 2008, Vol.31, S113-S120. doi:https://doi.org/10.2337/dc08-s227

Hypoglycemia in Type 1 Diabetes: A still unresolved problem in the era of insulin analogs and pump therapy

Shlomit Shalitin, MD; Moshe Phillip, MD

Abstracts

View articletitled, Hypoglycemia in Type 1 Diabetes: A still unresolved problem in the era of insulin analogs and pump therapy

Open the PDF for in another window

Topics: hypoglycemia , insulin analogs , diabetes mellitus, type 1 , insulin

Diabetes Care February 2008, Vol.31, S121-S124. doi:https://doi.org/10.2337/dc08-s228

Combined Therapy With Insulin Plus Oral Agents: Is There Any Advantage? : An argument in favor

Matthew C. Riddle, MD

Abstracts

View articletitled, Combined Therapy With Insulin Plus Oral Agents: Is There Any Advantage? : An argument in favor

Open the PDF for in another window

Topics: insulin , psychotherapy, multiple , hypoglycemia , metformin , glycemic control

Diabetes Care February 2008, Vol.31, S125-S130. doi:https://doi.org/10.2337/dc08-s231

Treatment of Type 2 Diabetes With Combined Therapy : What are the pros and cons?

Massimo Massi-Benedetti; Marco Orsini-Federici

Abstracts

View articletitled, Treatment of Type 2 Diabetes With Combined Therapy : What are the pros and cons?

Open the PDF for in another window

Topics: diabetes mellitus, type 2 , insulin

Diabetes Care February 2008, Vol.31, S131-S135. doi:https://doi.org/10.2337/dc08-s233

Insulin as a First-Line Therapy in Type 2 Diabetes: Should the use of sulfonylureas be halted?

Eberhard Standl, MD; Oliver Schnell, MD

Abstracts

View articletitled, Insulin as a First-Line Therapy in Type 2 Diabetes: Should the use of sulfonylureas be halted?

Open the PDF for in another window

Topics: diabetes mellitus, type 2 , insulin , sulfonylurea compounds

Diabetes Care February 2008, Vol.31, S136-S139. doi:https://doi.org/10.2337/dc08-s234

Long-Acting Insulin Analogs Versus Insulin Pump Therapy for the Treatment of Type 1 and Type 2 Diabetes

John C. Pickup, DPHIL, FRCPATH; Eric Renard, MD, PHD

Abstracts

View articletitled, Long-Acting Insulin Analogs Versus Insulin Pump Therapy for the Treatment of Type 1 and Type 2 Diabetes

Open the PDF for in another window

Topics: diabetes mellitus, type 1 , diabetes mellitus, type 2 , hypoglycemia , insulin , insulin glargine

Diabetes Care February 2008, Vol.31, S140-S145. doi:https://doi.org/10.2337/dc08-s235

The Nuts and Bolts of Achieving End Points With Real-Time Continuous Glucose Monitoring

Howard A. Wolpert, MD

Abstracts

View articletitled, The Nuts and Bolts of Achieving End Points With Real-Time Continuous Glucose Monitoring

Open the PDF for in another window

Topics: continuous glucose monitoring , glucose , hypoglycemia , blood glucose , insulin

Diabetes Care February 2008, Vol.31, S146-S149. doi:https://doi.org/10.2337/dc08-s238

Glycemic Variability: Should we and can we prevent it?

Louis Monnier, MD; Claude Colette, PHD

Abstracts

View articletitled, Glycemic Variability: Should we and can we prevent it?

Open the PDF for in another window

Topics: glucose , oxidative stress , fasting , postprandial period

Diabetes Care February 2008, Vol.31, S150-S154. doi:https://doi.org/10.2337/dc08-s241

Natural History of Cardiovascular Disease in Patients With Diabetes: Role of hyperglycemia

Zvonko Milicevic, MD, PHD; Itamar Raz, MD; Scott D. Beattie, PHD; Barbara N. Campaigne, PHD; Samiha Sarwat, MS; Elwira Gromniak, MD; Irina Kowalska, MD; Edvard Galic, MD; Meng Tan, MD; Markolf Hanefeld, MD, PHD

Abstracts

View articletitled, Natural History of Cardiovascular Disease in Patients With Diabetes: Role of hyperglycemia

Open the PDF for in another window

Topics: cardiovascular diseases , cardiovascular event , diabetes mellitus, type 2 , heart disease risk factors , hyperglycemia

Diabetes Care February 2008, Vol.31, S155-S160. doi:https://doi.org/10.2337/dc08-s240

Islet Inflammation in Type 2 Diabetes: From metabolic stress to therapy

Marc Y. Donath, MD; Desiree M. Schumann, PHD; Mirjam Faulenbach, MD; Helga Ellingsgaard, PHD; Aurel Perren, MD; Jan A. Ehses, PHD

Abstracts

View articletitled, Islet Inflammation in Type 2 Diabetes: From metabolic stress to therapy

Open the PDF for in another window

Topics: cytokine , diabetes mellitus, type 2 , inflammation , interleukins , dyslipidemias

Diabetes Care February 2008, Vol.31, S161-S164. doi:https://doi.org/10.2337/dc08-s243

Is Pancreatic Diabetes (Type 3c Diabetes) Underdiagnosed and Misdiagnosed?

Philip D. Hardt, MD, PHD; Mathias D. Brendel, MD; Hans U. Kloer, MD, PHD; Reinhard G. Bretzel, MD, PHD

Abstracts

View articletitled, Is Pancreatic Diabetes (Type 3c Diabetes) Underdiagnosed and Misdiagnosed?

Open the PDF for in another window

Topics: exocrine pancreatic insufficiency , pancreas , pancreatic diseases , incretin , misdiagnosis

Diabetes Care February 2008, Vol.31, S165-S169. doi:https://doi.org/10.2337/dc08-s244

Section II: Diabetes Complications and Hypertension-Novel Insights into Pathophysiology and Management

NADPH Oxidases, Reactive Oxygen Species, and Hypertension : Clinical implications and therapeutic possibilities

Tamara M. Paravicini, PHD; Rhian M. Touyz, MD, PHD

Abstracts

View articletitled, NADPH Oxidases, Reactive Oxygen Species, and Hypertension : Clinical implications and therapeutic possibilities

Open the PDF for in another window

Topics: antioxidants , hypertension , oxidase , oxidative stress , reactive oxygen species

Diabetes Care February 2008, Vol.31, S170-S180. doi:https://doi.org/10.2337/dc08-s247

Possible Role of Oxidative Stress in the Pathogenesis of Hypertension

Antonio Ceriello, MD

Abstracts

View articletitled, Possible Role of Oxidative Stress in the Pathogenesis of Hypertension

Open the PDF for in another window

Topics: hypertension , oxidative stress , antioxidants

Diabetes Care February 2008, Vol.31, S181-S184. doi:https://doi.org/10.2337/dc08-s245

Does Increased Oxidative Stress Cause Hypertension?

Ehud Grossman, MD

Abstracts

View articletitled, Does Increased Oxidative Stress Cause Hypertension?

Open the PDF for in another window

Topics: hypertension , oxidative stress , blood pressure

Diabetes Care February 2008, Vol.31, S185-S189. doi:https://doi.org/10.2337/dc08-s246

Albuminuria: A Great Risk Marker, but an Underestimated Target in Diabetes

Dick de Zeeuw, MD; Itamar Raz, MD

Abstracts

View articletitled, Albuminuria: A Great Risk Marker, but an Underestimated Target in Diabetes

Open the PDF for in another window

Topics: albuminuria , kidney

Diabetes Care February 2008, Vol.31, S190-S193. doi:https://doi.org/10.2337/dc08-s248

Microalbuminuria in Type 2 Diabetes and Hypertension: A marker, treatment target, or innocent bystander?

Seema Basi, MD, MSCI; Pierre Fesler, MD; Albert Mimran, MD; Julia B. Lewis, MD

Abstracts

View articletitled, Microalbuminuria in Type 2 Diabetes and Hypertension: A marker, treatment target, or innocent bystander?

Open the PDF for in another window

Topics: albuminuria , diabetes mellitus, type 2 , hypertension , microalbuminuria , kidney

Diabetes Care February 2008, Vol.31, S194-S201. doi:https://doi.org/10.2337/dc08-s249

Abnormal Glomerular Permeability Characteristics in Diabetic Nephropathy: Implications for the therapeutic use of low–molecular weight heparin

Edmund J. Lewis, MD; Xiulong Xu, PHD

Abstracts

View articletitled, Abnormal Glomerular Permeability Characteristics in Diabetic Nephropathy: Implications for the therapeutic use of low–molecular weight heparin

Open the PDF for in another window

Topics: diabetic nephropathy , heparin , heparitin sulfate , kidney glomerulus , low-molecular-weight heparin

Diabetes Care February 2008, Vol.31, S202-S207. doi:https://doi.org/10.2337/dc08-s251

Primary Prevention of Cardiovascular Disease in People With Dysglycemia

Cristina Bianchi, MD; Roberto Miccoli, MD, PHD; Giuseppe Penno, MD; Stefano Del Prato, MD

Abstracts

View articletitled, Primary Prevention of Cardiovascular Disease in People With Dysglycemia

Open the PDF for in another window

Topics: cardiovascular diseases , heart disease risk factors , hyperglycemia , glucose , diabetes mellitus, type 2

Diabetes Care February 2008, Vol.31, S208-S214. doi:https://doi.org/10.2337/dc08-s256

Cardiovascular Complications in Diabetes: Targets and interventions

Alin O. Stirban, MD; Diethelm Tschoepe, MD

Abstracts

View articletitled, Cardiovascular Complications in Diabetes: Targets and interventions

Open the PDF for in another window

Topics: atherosclerosis , cardiac complications , critical illness , endothelial dysfunction , endothelium

Diabetes Care February 2008, Vol.31, S215-S221. doi:https://doi.org/10.2337/dc08-s257

Should We Prescribe Statin and Aspirin for Every Diabetic Patient?: Is it time for a polypill?

Harm Wienbergen, MD; Jochen Senges, MD, PHD, FESC, FACC; Anselm K. Gitt, MD, FESC

Abstracts

View articletitled, Should We Prescribe Statin and Aspirin for Every Diabetic Patient?: Is it time for a polypill?

Open the PDF for in another window

Topics: aspirin , statins , polycap

Diabetes Care February 2008, Vol.31, S222-S225. doi:https://doi.org/10.2337/dc08-s253

Should We Be More Aggressive in the Therapy Against Cardiovascular Risk Factors?: Should we prescribe statin and aspirin for every diabetic patient, or is it time for a polypill?

Alin O. Stirban, MD; Diethelm Tschoepe, MD

Abstracts

View articletitled, Should We Be More Aggressive in the Therapy Against Cardiovascular Risk Factors?: Should we prescribe statin and aspirin for every diabetic patient, or is it time for a polypill?

Open the PDF for in another window

Topics: aspirin , heart disease risk factors , polycap , statins

Diabetes Care February 2008, Vol.31, S226-S228. doi:https://doi.org/10.2337/dc08-s254

Efficacy and Safety of Rimonabant for Improvement of Multiple Cardiometabolic Risk Factors in Overweight/Obese Patients: Pooled 1-year data from the Rimonabant in Obesity (RIO) program

Luc Van Gaal, MD; Xavier Pi-Sunyer, MD; Jean-Pierre Després, PHD; Christine McCarthy, MD; André Scheen, MD

Abstracts

View articletitled, Efficacy and Safety of Rimonabant for Improvement of Multiple Cardiometabolic Risk Factors in Overweight/Obese Patients: Pooled 1-year data from the Rimonabant in Obesity (RIO) program

Open the PDF for in another window

Topics: rimonabant , weight reduction , obesity , waist circumference , overweight

Diabetes Care February 2008, Vol.31, S229-S240. doi:https://doi.org/10.2337/dc08-s258

Targets for Intervention in Dyslipidemia in Diabetes

Gerald H. Tomkin, MD

Abstracts

View articletitled, Targets for Intervention in Dyslipidemia in Diabetes

Open the PDF for in another window

Topics: atherosclerosis , cholesterol , chylomicrons , diabetic dyslipidemia , dyslipidemias

Diabetes Care February 2008, Vol.31, S241-S248. doi:https://doi.org/10.2337/dc08-s260

Diastolic Pressure in Type 2 Diabetes: Can target systolic pressure be reached without “diastolic hypotension”?

Etty Osher, MD; Naftali Stern, MD

Abstracts

View articletitled, Diastolic Pressure in Type 2 Diabetes: Can target systolic pressure be reached without “diastolic hypotension”?

Open the PDF for in another window

Topics: blood pressure , diabetes mellitus, type 2 , diastole , diastolic blood pressure , hypertension

Diabetes Care February 2008, Vol.31, S249-S254. doi:https://doi.org/10.2337/dc08-s262

Statement of Retraction

Extract

View articletitled, Statement of Retraction

Open the PDF for in another window

Topics: diabetic neuropathies , diabetic polyneuropathies , duplicate publications , neuropathic pain

Diabetes Care January 2012, Vol.31, S255. doi:https://doi.org/10.2337/dc08-s263

Section III: Obesity-The Rising Epidemic

Insulin Resistance and Hyperinsulinemia: Is hyperinsulinemia the cart or the horse?

Michael H. Shanik, MD; Yuping Xu, MD; Jan Škrha, MD, DSC; Rachel Dankner, MD, MPH; Yehiel Zick, PHD; Jesse Roth, MD

Abstracts

View articletitled, Insulin Resistance and Hyperinsulinemia: Is hyperinsulinemia the cart or the horse?

Open the PDF for in another window

Topics: hyperinsulinism , insulin , insulin resistance , hormones , glucose

Diabetes Care February 2008, Vol.31, S262-S268. doi:https://doi.org/10.2337/dc08-s264

Treatment Modalities of Obesity: What fits whom?

Vojtĕch Hainer, MD, PHD; Hermann Toplak, MD, PHD; Asimina Mitrakou, MD

Abstracts

View articletitled, Treatment Modalities of Obesity: What fits whom?

Open the PDF for in another window

Topics: obesity , weight reduction , weight maintenance regimens

Diabetes Care February 2008, Vol.31, S269-S277. doi:https://doi.org/10.2337/dc08-s265

Is Weight Loss Beneficial for Reduction of Morbidity and Mortality?: What is the controversy about?

Peter M. Nilsson, MD

Abstracts

View articletitled, Is Weight Loss Beneficial for Reduction of Morbidity and Mortality?: What is the controversy about?

Open the PDF for in another window

Topics: obesity , weight reduction , diabetes mellitus, type 2

Diabetes Care February 2008, Vol.31, S278-S283. doi:https://doi.org/10.2337/dc08-s268

Can Gut Hormones Control Appetite and Prevent Obesity?

Owais B. Chaudhri, PHD; Katie Wynne, PHD; Stephen R. Bloom, MD, DSC

Abstracts

View articletitled, Can Gut Hormones Control Appetite and Prevent Obesity?

Open the PDF for in another window

Topics: appetite or desire , desire for food , ghrelin , glucagon-like peptide 1 , gut hormones

Diabetes Care February 2008, Vol.31, S284-S289. doi:https://doi.org/10.2337/dc08-s269

Is Type 2 Diabetes an Operable Intestinal Disease?: A provocative yet reasonable hypothesis

Francesco Rubino, MD

Abstracts

View articletitled, Is Type 2 Diabetes an Operable Intestinal Disease?: A provocative yet reasonable hypothesis

Open the PDF for in another window

Topics: diabetes mellitus, type 2 , surgical procedures, operative , bypass , intestinal diseases , weight reduction

Diabetes Care February 2008, Vol.31, S290-S296. doi:https://doi.org/10.2337/dc08-s271

Bariatric Surgery in Patients With Morbid Obesity and Type 2 Diabetes

Guntram Schernthaner, MD; John M. Morton, MD

Abstracts

View articletitled, Bariatric Surgery in Patients With Morbid Obesity and Type 2 Diabetes

Open the PDF for in another window

Topics: bariatric surgery , obesity, morbid , surgical procedures, operative , weight reduction , obesity

Diabetes Care February 2008, Vol.31, S297-S302. doi:https://doi.org/10.2337/dc08-s270

Abdominal Fat and Sleep Apnea: The chicken or the egg?

Giora Pillar, MD, PHD; Naim Shehadeh, MD

Abstracts

View articletitled, Abdominal Fat and Sleep Apnea: The chicken or the egg?

Open the PDF for in another window

Topics: abdomen , obesity , obstructive sleep apnea , sleep , sleep apnea syndromes

Diabetes Care February 2008, Vol.31, S303-S309. doi:https://doi.org/10.2337/dc08-s272

Metabolic Complications of Childhood Obesity: Identifying and mitigating the risk

Ram Weiss, MD, PHD; Francine Ratner Kaufman, MD

Abstracts

View articletitled, Metabolic Complications of Childhood Obesity: Identifying and mitigating the risk

Open the PDF for in another window

Topics: childhood obesity , obesity , child , non-alcoholic fatty liver disease , adolescent

Diabetes Care February 2008, Vol.31, S310-S316. doi:https://doi.org/10.2337/dc08-s273

Issues

Cover Image

Proceedings of the 1st World Congress on Controversies in Diabetes, Obesity and Hypertension (CODHy)

Introduction

Section I: Diabetes-What Is New in the Management and Understanding of the Disease?

Section II: Diabetes Complications and Hypertension-Novel Insights into Pathophysiology and Management

Statement of Retraction

Section III: Obesity-The Rising Epidemic

Email alerts

RSS Feeds

Journals

Books

Clinical Compendia

News

Other

About

Resources

This Feature Is Available To Subscribers Only